SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.54 Cr | ₹0.46 Cr | - | ₹0.40 Cr | - |
What is the latest Contingent Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.54 Cr |
| Mar2024 | ₹0.46 Cr |
| Mar2023 | - |
| Mar2022 | ₹0.40 Cr |
| Mar2021 | - |
How is Contingent Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.54 Cr | 230.82 | |
| Mar2024 | ₹0.46 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.40 Cr | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹97.0 Cr | -12.6% | -21.4% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -12.6% |
-21.4% |
-24% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses